ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
127.34
-3.56
(-2.72%)
Cerrado 29 Marzo 3:00PM
Realtime Data
Gráfico avanzado

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
127.34
Postura de Compra
127.28
Postura de Venta
127.36
Volume Operado de la Acción
4,571
128.44 Rango del Día 131.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
130.90
Precio de Apertura
130.74
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

VNRA Últimas noticias

No hay noticias para mostrar aún.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PRTGPortage Biotech Inc
US$ 9.60
(103.82%)
29.92M
LXRXLexicon Pharmaceuticals Inc
US$ 0.5741
(65.16%)
405.3M
DBVTDBV Technologies SA
US$ 6.12
(56.52%)
21.8M
MYSZMy Size Inc
US$ 1.79
(42.06%)
11.89M
LXEHLixiang Education Holding Company Ltd
US$ 17.70
(32.78%)
217.53k
STSSSharps Technology Inc
US$ 0.0421
(-72.43%)
214.43M
MISTMilestone Pharmaceuticals Inc
US$ 0.88
(-60.89%)
33.47M
XTIAXTI Aerospace Inc
US$ 1.23
(-50.00%)
1.82M
LGMKLogicMark Inc
US$ 0.0258
(-49.41%)
161.36M
ICONIcon Energy Corporation
US$ 0.0516
(-48.40%)
27.6M
LXRXLexicon Pharmaceuticals Inc
US$ 0.5741
(65.16%)
405.3M
DMNDamon Inc
US$ 0.0346
(-22.42%)
314.35M
NVDANVIDIA Corporation
US$ 109.67
(-1.58%)
229.88M
STSSSharps Technology Inc
US$ 0.0421
(-72.43%)
214.43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.845
(-7.30%)
200.21M
monocle monocle 20 segundos hace
They've been up front 2-1 debt/equity ration, dilution is coming.

Read up on Stellantis investments in mines, you shouldn't expect much as they are very dilutive and don't bring in very much cash. They bought a 19.99% stake in Kuniko for $5 million, an 11.5% stake in Alliance Nickel f
NB
hedge_fun hedge_fun 35 segundos hace
Good riddance. What a loser…….

“If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy,” a spokesperson at HHS said.
QaB2i QaB2i 4 minutos hace
Wrong guess mate. 
TWOH
NASDAQ2020 NASDAQ2020 4 minutos hace
Stop bait up yuhself, fassy. ELTP
ELTP
Bjones2 Bjones2 5 minutos hace
Paul has completed our Financials and Filed with SEC

With $28 Million in debt reduction with Artizen divestiture, PVSP has a chance of climbing out of the ditch now that $28 Million in debt is off our back.

Time to announce some NEW licensing deals for out agriculture
PVSP
Pisd Pisd 8 minutos hace
..OTC pink..ouchie, thought would be saved w/buyout, oh well...
ME
k9narc k9narc 11 minutos hace
Who ever chose them, forgot deepfried Prairie Oysrers.

Not happy.
louieforpar louieforpar 12 minutos hace
Demented,poorly educated as the Rapist/in-chief calls his supporters.
To think they truly believe this administration is good for this country is beyond comprehension. 
$7.00 or Nothing $7.00 or Nothing 16 minutos hace
0 for the story
10 for the effort
10 for the colors.
ELTP
hopester hopester 16 minutos hace
I expected that response. Empty as usual. Devoid of substantive statements . And once again, no reasons given for your support .
Keep the comedy coming.
FCEL
cowtown jay cowtown jay 16 minutos hace
""It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies," Marks wrote in a resignation letter addressed to acting FDA Commissioner Sara Brenner, the WSJ reported."

https://www.reut
dws dws 16 minutos hace
Crowd
SLV
dws dws 16 minutos hace
Watch PSLV Monday. The Reddit crows is at it again. 
PSLV
RickNagra RickNagra 17 minutos hace
$8 by Friday.
FNMA
louieforpar louieforpar 20 minutos hace
Always liked the craftinesses to the post. Personally love the OPSEC acronym. 
edbi46 edbi46 25 minutos hace
Actipatch Smart Insole -- NEW & IMPROVED!!!

https://unovita.com/products/smart-insoletm-heel-pain-relief?variant=47506240471349

https://shop.renovabiomed.it/it/prodotti/3402-soletta-e-fascia-smart-insole.html?sfnsn=wa

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
BMI LMT QUBT
JSmith5 JSmith5 28 minutos hace
Well, if a good dividend stream results from the GSE’s,

I was going to answer somewhere along these lines. It would be reasonable for the GSEs to pay out about $20B per year as dividends. They may pay more or less, but the attractiveness of the stocks' dividends will be the star fea
FNMA
Seminole Red Seminole Red 30 minutos hace
I wonder if that would have won money in a pay contest
Vulcanized Crawler Vulcanized Crawler 32 minutos hace
right u r
XLMUSD
brooklyn13 brooklyn13 33 minutos hace
If there are any Jews who give lie to the myth of superior Jewish intelligence it’s Lee Zeldin and you
Vulcanized Crawler Vulcanized Crawler 35 minutos hace
so far following what i said. 2.09
experience pays off. manipulation lives in cryptos as it does in equities.
take advantage.
XRPUSD
SkeBallLarry SkeBallLarry 36 minutos hace
" a little Fun break " >>

((( Hit Full Screen & Volume up )))

https://youtu.be/L6Sw6amNg5s
dennisdave dennisdave 37 minutos hace
You guys can have at it, count me out, makes no sense to put out content like this while we are on verge of MHRA approval and proceeding catalyst if you are truly long, all this does is scare away new investors. Oh, and what about the patients hope of approval and funding for the life saving DCVAX-L
NWBO
cottonisking cottonisking 38 minutos hace
⭐️⭐️⭐️⭐️⭐️ The guarantee may be amended only with the prior approval of the holders of not less than 662/3% in aggregate liquidation amount of the outstanding preferred and common securities. No vote will be required, however, for any changes that do not materially adversely affect the rights of hol
LEHNQ